MD Anderson Cancer Center’s Strategic Industry Ventures (Houston). Through collaborations with faculty and working with the health system’s Office of Technology Commercialization, MD Anderson’s Strategic Industry Ventures seeks to bring new drugs, diagnostics, devices and information solutions to market to benefit cancer patients. The OTC also looks for viable technologies to turn into startups. Since 1987 the office has played a part in creating 11 affiliated companies that have raised more than $300 million. Some of SIV’s partner companies include Abbvie, Amgen and Pfizer
 |
 |
 |
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.